The company launched in 2023 with $90 million in funding from organizations including Johnson & Johnson’s venture capital arm.
Makary’s exit ends a turbulent run marred by leadership upheaval, mass layoffs, political pressure and public spats with ...
The decision to wind down the operation in Santa Rosa in about two years comes as the medtech giant combines several ...
The deal for Amplitude’s intravascular lithotripsy platform, which closed last week, included $435 million upfront and up to ...
PathAI makes AI models that help with the analysis of patient tissue samples and diagnostic tools. Roche has partnered with ...
With an intravascular lithotripsy platform, Stryker will enter a booming market that has attracted investment from Johnson & Johnson, Boston Scientific and Abbott.
CEO Kevin Lobo said the attack had a “big impact” on first-quarter results. However, the company maintained its full-year ...
The new version of Tandem’s Mobi pump would be the diabetes technology company’s first tubeless device. Tandem Diabetes Care ...
BD named Vitor Roque as chief financial officer Thursday, ending the medtech company’s seven-month search for a permanent ...
The first-in-human study showed no adverse events and a 100% rate of cecal intubation, where the endoscope is guided to the ...
The company wants AI to support all complex diagnostic decisions by 2030 to prevent diagnostic errors and delays.
Despite saying the levy was “unauthorized by law,” the U.S. Court of International Trade did not issue a universal stay.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results